Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Search

Search Results for drugs

Price concession for 248 products in September
News

Price concession for 248 products in September; includes hypertension, diabetes drugs

Pharmacy owners are often forced to purchase medicines without knowing whether the NHS will fully reimburse the price

Police raids in Rochdale unearth illicit drugs, four arrested
News

Police raids in Rochdale unearth illicit drugs, four arrested

A significant proportion of the haul consisted of prescription-type medication, alongside bodybuilding and weight-loss drugs

RCPharm urges action as Scottish drug deaths rise 11%
News

RCPharm urges action as Scottish drug deaths rise 11%

Pharmacy’s role in preventing drug deaths remains underused, with key recommendations still to be addressed, the College has warned

Scottish pub owners blame weight-loss drugs for slim turnouts
Obesity & Weight Management

Scottish pub owners blame weight-loss drugs for slim turnouts

Scottish Licensed Trade Association survey shows that weight-loss drugs is one of the reasons for decline in sales

Three antiarrhythmic drugs out of stock DHSC
News

Three antiarrhythmic drugs out of stock: DHSC

Clinicians should not initiate new patients on propafenone 150mg tablets until the supply issue has resolved

Drug recall: Antidepressant pulled over manufacturing error
Mental Health & Wellbeing

Drug recall: Antidepressant pulled over manufacturing error

It came to light after a complaint was filed by a patient

Half the people in UK are unaware that advertising GLP-1 drugs is against law: ASA
Obesity & Weight Management

Half the people in UK are unaware that advertising GLP-1 drugs is against law: ASA

'An increasingly sophisticated marketing is creating new risks in the weight-loss advertising landscape'

Experts discover a new threat from weight loss drugs
Obesity & Weight Management

Experts discover a new threat from weight loss drugs

The Medicines and Healthcare products Regulatory Agency (MHRA) has earlier revised the product information of semaglutide, indicating a rare risk of vision loss